Acupuncture needle with lidocaine may ease migraines
NCT ID NCT07067853
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested whether injecting lidocaine into the GB20 acupoint (at the back of the neck) can reduce migraine attacks. Thirty adults with migraines received either weekly lidocaine injections for four weeks or daily propranolol pills. Researchers tracked headache frequency, duration, pain intensity, and disability over two months to see if the injections work as well as standard medication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- lidocaine 2% injection at GB20 acupoint
- What this could lead to
- If it works, this could offer a safe, non-oral alternative for migraine relief with fewer daily pills.
- What could go wrong
- This is a small, completed trial with only 30 participants, so results may not apply widely. Lidocaine injections can cause pain, infection, or skin irritation at the injection site.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universitas Indonesia
Jakarta Pusat, DKI Jakarta, 10430, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a numbing nose treatment stop migraine pain in its tracks?
- Can migraine meds be safe while breastfeeding? a new study investigates
- Could a symptom registry unmask hidden migraine variants?
- A migraine-blocking antibody tested in children as young as 6
- Mind over migraine: brain network may explain why some expect side effects
- The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?